Hualu Network Group
中文版
search
Home Page
About us
Our Values
Development Milestone
News
News
Products
Product List for API
Recommended API
Product List for Finished Drug
Product list for Chemicals and Intermediates
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
Contact Us
Investor Relation
Information transparency and trust in peers
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
PERIODIC REPORT
Home Page
/
Investor Relation
/
PERIODIC REPORT
05
2025-02
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2025
20
2025-01
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant ...
02
2025-01
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2024
总条数:
23
条
＜
1
2
3
＞
跳转到:
页
跳转
Copyright © Shandong Xinhua Pharmaceutical Co., Ltd
鲁ICP备09066031号
鲁公安备案号 3703900200041
(鲁)-非经营性-2015-0068
Technical Support:CR DIGITAL
Xinhua Pharmaceutical
